Cannabis for Palliative Care in Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

May 30, 2028

Study Completion Date

June 30, 2028

Conditions
SleepAnxietyDepressionPain
Interventions
DRUG

fsCBD Cannabidiol

Full Spectrum hemp-derived CBD (fsCBD; 200mg CBD/4mg THC) capsules produced by Ecofibre/Ananda Hemp will be used

DRUG

Placebo

Placebo arm; capsules produced by Ecofibre/Ananda Hemp will be used

DRUG

bsCBD Cannabidiol

Broad spectrum hemp-derived CBD (bsCBD; 200mg CBD) capsules produced by Ecofibre/Ananda Hemp will be used

Trial Locations (1)

80045

RECRUITING

Anschutz Health Sciences Building, Aurora

All Listed Sponsors
lead

University of Colorado, Boulder

OTHER